1Appelbaum FR, Gundacker H, Head DR, et al. Age and acute myeloid leukemia. Blood 2006 ; 107 ( 9 ) : 3481 -3485. 被引量：1
2Sperr WR, Piribauer M, Wimazal F, et al. A novel effective and safe consolidation for patients over 60 years with acute myeloid leukemia; intermediate dose cytarabine (2 × 1 g/m^2 on days 1, 3 and 5). Clin Cancer Res 2004; 10(12pt1):3965- 5971. 被引量：1
3Rowe JM, Neuberg D, Friedenberg W, et al. A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group. Blood 2004 ; 103 (2) : 479-485. 被引量：1
7Guo M, Hu KX, Yu CL, et al. Infusion of HLA-mismatched peripheralblood stem ceils improves the outcome of chemotherapy for acute mye-loid leukemia in elderly patients. Blood,2011,117:936-941. 被引量：1
8Lv M,Huang XJ. Allogeneic hematopoietic stem cell transplantation inChina: where we are and where to go. J Hematol Oncol,2012,5 :10. 被引量：1
9Li HW,Sykes M. Emerging concepts in haematopoietic cell transplanta-tion. Nat Rev Immunol,2012,12-403-416. 被引量：1
10Mackinnon S, Chakraverty R. Families get mobilized to treat AML.Blood,2011,117:746-748. 被引量：1
